Explosion of diabetes cases in UK

2 March 2009

The UK is seeing an explosion of diabetes linked to growing obesity rates, experts are warning. From 1997 to 2003 there was a 74% rise in  new cases of the disease and, by 2005, more than 4% of the population  was classed as having diabetes - nearly double the rate of 10 years  earlier. The bulk of cases are type 2 diabetes -which is linked to being  overweight or obese - the Journal of Epidemiology and Community Health  reports.

The findings suggest that rates of diabetes are increasing at a faster  rate in the UK than they are in the USA, where prevalence of the disease  is already one of the highest in the world. Of more than 42,642 people  who were newly-diagnosed with the disease between 1996 and 2005, just  over 1,250 had the inherited insulin-dependent type 1 diabetes, and more  than 41,000 had later-onset type 2 disease, which is linked to  lifestyle. While the numbers of new cases of type 1 diabetes remained  fairly constant over the decade, newly-diagnosed type 2 disease did not.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight